Serum amyloid a protein as a potential biomarker in predicting acute onset and association with in-hospital death in acute aortic dissection

Table 1 Demographic and laboratory parameters of participants included in this study

	Control (n = 63)	Angina (n = 20)	AAD (n = 87)	P-value	TAAD (n = 37)	TBAD (n = 50)	P-value
				AAD vs Control
				AAD vs Angina
Male, n (%)	43 (68.25%)	15(75.00%)	65 (74.71%)	0.657	27 (72.97%)	38 (76.00%)	0.75
Hypertension, n (%)	21 (33.33%)	8(40.00%)	54 (62.69%)	0.002*	27 (72.97%)	27 (54.00%)	0.073
Smoking, n (%)	19 (30.16%)	7(35.00%)	31 (35.63)	0.774	12 (32.43%)	19 (38.00%)	0.594
DM, n (%)	10 (15.87%)	6(30.00%)	26 (29.89%)	0.123	11 (29.73%)	15 (30.00%)	0.978
Age, Yr	53.44 ± 11.52	57.80 ± 2.11	53.87 ± 11.42	0.957	53.32 ± 11.12	54.1 ± 11.73	0.848
				0.355
BMI	21.8 ± 3.68	23.70 ± 0.73	22.87 ± 5.14	0.357	22.24 ± 3.92	24.02 ± 5.99	0.149
				0.702
HR, bmp	78.06 ± 9.6	79.45 ± 1.68	89.46 ± 12.68	< 0.001***	90.49 ± 11.86	88.21 ± 13.28	0.273
				0.001***
WBC, × 10⁹/L	5.83 ± 0.77	6.39 ± 0.40	10.74 ± 4.24	< 0.001***	11.54 ± 4.50	10.06 ± 3.92	0.198
				< 0.001***
HGB, g/L	150.98 ± 17.68	135.50 ± 4.08	132.39 ± 20.97	< 0.001***	128.63 ± 17.86	135.61 ± 23.03	0.052
				0.297
PLT, × 10⁹/L	173.3 ± 43.14	201.35 ± 13.27	190.59 ± 68.15	0.194	199.34 ± 67.05	183.12 ± 69.00	0.196
				0.744
FPG, mmol/L	4.97 ± 4.87	5.54 ± 0.24	7.21 ± 2.42	0.001***	7.61 ± 2.84	6.92 ± 2.05	0.355
				0.155
SAA, mg/L	0.36 ± 0.08	0.72 ± 0.40	4.43 ± 0.31	< 0.001***	4.22 ± 0.33	4.58 ± 0.48	0.595
				0.029*

Note, AAD acute aortic dissection, TAAD type A aortic dissection, TBAD type B aortic dissection, BMI body mass index, HR heart rate, DM diabetes mellitus, WBC white blood cell, HGB hemoglobin, PLT platelet, FPG fast plasma glucose, SAA serum amyloid A. *P<0.05; **P<0.01; ***P<0.001

ISSN: 1471-2261